STRATA Skin Sciences (SSKN) Gains from Sales and Divestitures (2018 - 2024)

STRATA Skin Sciences has disclosed Gains from Sales and Divestitures across 7 years of filings, most recently posting $2265.0 for Q4 2024.

• Gains from Sales and Divestitures for Q4 2024 came in at $2265.0, down 87.38% year-over-year; the trailing twelve-month figure through Dec 2024 was $2265.0 (down 87.38% YoY), and the FY2024 annual result was $2265.0, down 87.38% from the prior year.
• Gains from Sales and Divestitures came in at $2265.0 for Q4 2024 at STRATA Skin Sciences, roughly flat from $2265.0 in the prior quarter.
• In the past five years, Gains from Sales and Divestitures ranged from a high of $158407.0 in Q4 2022 to a low of $1414.0 in Q2 2024.
• The 5-year median for Gains from Sales and Divestitures is $55547.0 (2020), against an average of $64465.6.
• Across the five-year window, Gains from Sales and Divestitures jumped 298.66% in 2023 and plunged 98.23% in 2024, its largest moves.
• STRATA Skin Sciences' Gains from Sales and Divestitures stood at $68091.0 in 2020, then soared by 114.95% to $146364.0 in 2021, then gained by 8.23% to $158407.0 in 2022, then plunged by 88.67% to $17944.0 in 2023, then slumped by 87.38% to $2265.0 in 2024.
• The last three Gains from Sales and Divestitures figures came in at $2265.0 (Q4 2024), $2265.0 (Q3 2024), and $1414.0 (Q2 2024), per Business Quant data.